Division of Urology (Surgery), Penn State Milton S. Hershey Medical Center, Hershey, PA 17033-0850, USA.
BJU Int. 2013 May;111(6):891-6. doi: 10.1111/j.1464-410X.2012.11531.x. Epub 2013 Jan 18.
WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: The topic of radiation safety has been hotly debated not only in the mainstream media, but also in the urological literature. Radiation exposure has been examined in urological diseases such as testicular cancer and urinary stone disease, with resultant recommendations for modifying surveillance imaging. Radiation risk with respect to surveillance regimens after RCC surgery has yet to be examined. We consider this largely to be a result of RCC typically affecting older patients in whom cumulative radiation exposure may be less of a consideration. However, current population data emphasize that RCC diagnosis and therapy have an increasing impact upon younger patients with a longer life expectancy after treatment. Therefore, radiation considerations in this cohort of patients may be significant.
To determine the 10-year cumulative radiation exposure incurred on different surveillance imaging protocols after surgery for pT1 renal cell carcinoma (RCC).
The PubMed database was queried for surveillance protocols after surgery for RCC. There were two index lesions that were selected: (i) pT1a 3 cm, Fuhrman 2, clear cell and (ii) pT1b 5 cm, Fuhrman 3, clear cell. Exposure for single-phase chest computed tomography (CT), abdominal CT and chest X-ray were 7, 8 and 0.1 mSV, respectively. Calculations assumed biphasic CT scans, negative surgical margins and an Eastern Cooperative Oncology Group status of ≤1.
In total, 12 published surveillance regimens were identified. For the first lesion (pT1a, clear cell, Fuhrman 2), we observed significant variability in the proposed regimens, ranging from no imaging to several CT scans of both chest and abdomen. Cumulative incurred radiation exposure for this index patient was in the range 0-102 mSv (mean, 34 mSv). When considering the second tumour (pT1b, clear cell, Fuhrman 3), all studies recommended some form of follow-up imaging, although regimens once again varied from annual chest X-ray to multiple CT scans of chest and abdomen. Cumulative incurred radiation exposure in this scenario was in the range 0.5-450 mSv (mean, 89 mSV).
Surveillance protocols after surgery for early-stage RCC result in widely divergent levels of radiation exposure. Such considerations are increasingly paramount given concerns of radiation-induced secondary malignancies and present another reason to standardize follow-up protocols.
确定手术后 T1 期肾细胞癌 (RCC) 不同监测成像方案的 10 年累积辐射暴露量。
在 PubMed 数据库中查询了手术后 RCC 的监测方案。选择了两个索引病变:(i) 3 cm、Fuhrman 2、透明细胞的 pT1a 和 (ii) 5 cm、Fuhrman 3、透明细胞的 pT1b。单期胸部 CT(CT)、腹部 CT 和胸部 X 线的暴露量分别为 7、8 和 0.1 mSV。计算假设为双期 CT 扫描、阴性手术切缘和东部合作肿瘤组 (ECOG) 状态≤1。
共确定了 12 种已发表的监测方案。对于第一个病变 (pT1a、透明细胞、Fuhrman 2),我们观察到所提出的方案存在显著差异,范围从无影像学检查到胸部和腹部的多次 CT 扫描。对于该指数患者,累积辐射暴露量为 0-102 mSv(平均值 34 mSv)。当考虑第二个肿瘤 (pT1b、透明细胞、Fuhrman 3) 时,所有研究都建议采用某种形式的随访影像学检查,尽管方案再次从每年的胸部 X 线到胸部和腹部的多次 CT 扫描不等。在这种情况下,累积辐射暴露量在 0.5-450 mSv 之间(平均值 89 mSv)。
手术后早期 RCC 的监测方案导致辐射暴露水平存在广泛差异。鉴于对辐射诱导的继发性恶性肿瘤的担忧,这种考虑变得越来越重要,这也是标准化随访方案的另一个原因。